[Ip-health] New Version of 21st Century Cures Act Released, Marketing Exlusivity Provisions Appear to Be Removed

Jamie Love james.love at keionline.org
Wed Apr 29 16:00:19 PDT 2015

Andy says there is a place holder in the bill for incentives, so the
exclusivity provisions are apparently going to go back in at some point.

Apparently the placeholder on p.142, is this.

[Subtitle I—Repurposing Drugs for Serious and Life-Threatening Diseases and
Conditions  [SEC. 2151. [TO BE SUPPLIED.]

On Wed, Apr 29, 2015 at 2:35 PM, Andrew S. Goldman <
andrew.goldman at keionline.org> wrote:

> A new version of the 21st Century Cures Act has been released.  It is
> significantly shorter than the previous version (under 200 pages, down from
> ~400).  It would appear on initial glance that all provisions in the
> previous version regarding extensions of marketing exclusivity have been
> removed.  (In the previous version, these were sections 1063, 1222, 1241,
> 1261, and 5001.)
> http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/114/20150429DiscussionDraft.pdf

More information about the Ip-health mailing list